Screening for brain metastases (BM) in patients (pts) with stage III non-small cell lung cancer (NSCLC), magnetic resonance imaging (MRI) or dedicated contrast-enhanced computed tomography (dCE-CT)? A prospective observational study

Screening for brain metastases (BM) in patients (pts) with stage III non-small cell lung cancer (NSCLC), magnetic resonance imaging (MRI) or dedicated contrast-enhanced computed tomography (dCE-CT)? A prospective observational study

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; pp. viii488 - viii489
Main Authors: Schoenmaekers, J.J.A.O., Hendriks, L., Dingemans, A.-M.C., De Ruysscher, D., Bootsma, G., Schreurs, W., Westenend, M., Houben, R., Hofman, P., De Booij, M.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy291.002